ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years

October 25, 2013

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012

DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer

November 9, 1984

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

DeVita Emphasizes NCI Prevention In Statement To Senate Committee

February 15, 1980